Fulgent Genetics, Inc. (FLGT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 21.79 |
| Open | 21.77 |
| Bid | 21.70 x 200 |
| Ask | 21.79 x 100 |
| Day's range | 21.54 - 21.94 |
| 52-week range | 19.88 - 44.09 |
| Volume | |
| Avg. volume | 218,622 |
| Market cap | 650.854M |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.56 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.67 |
Simply Wall St.Fulgent Genetics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Fulgent Genetics ( NASDAQ:FLGT ) First Quarter 2024 Results Key Financial Results Revenue: US$64.5m (down 2.5% from 1Q...
Insider MonkeyFulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript May 3, 2024 Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to […]
- GuruFocus.com
Fulgent Genetics Inc (FLGT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ...
Despite a slight revenue dip, Fulgent Genetics showcases strategic advancements and robust future prospects in precision diagnostics and pharmaceutical development.
© 2024 Yahoo. All rights reserved.